Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML. Othman J, Potter N, Freeman SD, McCarthy N, et al. Blood 2025;146:1862-1867.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Othman J, Potter N, Freeman SD, McCarthy N, et al. Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML. Blood 2025;146:1862-1867.
PMID: 40768751